Advertisement

Hip Arthroscopy With Bone Marrow Aspirate Injection for Patients With Symptomatic Labral Tears and Early Degenerative Changes Shows Similar Improvement Compared With Patients Undergoing Hip Arthroscopy With Symptomatic Labral Tears Without Arthritis

Published:December 24, 2022DOI:https://doi.org/10.1016/j.arthro.2022.12.012

      Purpose

      To define the clinical effect of intra-articular injection of iliac crest–derived bone marrow aspirate concentrate (BMAC) at the time of hip arthroscopy in patients with symptomatic labral tears and early radiographic degenerative changes.

      Methods

      A retrospective review of a prospectively collected hip registry database was performed. Patients with symptomatic labral tears and Tönnis grade 1 or 2 degenerative changes who underwent labrum-preserving hip arthroscopy with BMAC injection were included and were matched with patients who underwent hip arthroscopy without BMAC injection. Patient-reported outcomes (PROs) collected preoperatively and up to 2 years postoperatively included the modified Harris Hip Score, Hip Outcome Score–Activities of Daily Living, Hip Outcome Score–Sport, and International Hip Outcome Tool 33 score. Clinical relevance was measured with the minimal clinically important difference, patient acceptable symptom state, and substantial clinical benefit for each outcome score.

      Results

      A total of 35 patients underwent labrum-preserving hip arthroscopy with BMAC injection and were matched with 35 control patients. There were no differences in demographic characteristics between the groups (P > .05). The BMAC group consisted of 22 patients (62.9%) with Tönnis grade 1 changes and 13 (37.1%) with Tönnis grade 2 changes, whereas all 35 control patients had Tönnis grade 0 hips. All PROs were significantly improved in both groups at 2 years, with no difference in improvement. The rate of failure requiring conversion to total hip arthroplasty was 14.3% (mean, 1.6 years postoperatively) in the BMAC group and 5.7% (mean, 7 years postoperatively) in the control group (P = .09). The difference in the frequency of patients achieving the minimal clinically important difference, patient acceptable symptom state, and substantial clinical benefit was not statistically significant between cohorts.

      Conclusions

      In a challenging group of patients with symptomatic labral tears and early radiographic degenerative changes, hip arthroscopy with BMAC injection results in statistically and clinically significant improvement in PROs comparable to a group of patients with nonarthritic hips undergoing hip arthroscopy at short-term follow-up.

      Level of Evidence

      Level III, retrospective comparative therapeutic trial.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Arthroscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kremers H.M.
        • Schilz S.R.
        • Van Houten H.K.
        • et al.
        Trends in utilization and outcomes of hip arthroscopy in the United States between 2005 and 2013.
        J Arthroplasty. 2017; 32: 750-755
        • Byrd J.W.
        • Jones K.S.
        Hip arthroscopy for labral pathology: Prospective analysis with 10-year follow-up.
        Arthroscopy. 2009; 25: 365-368
        • Byrd J.W.
        • Jones K.S.
        Prospective analysis of hip arthroscopy with 10-year followup.
        Clin Orthop Relat Res. 2010; 468: 741-746
        • Griffin D.R.
        • Dickenson E.J.
        • Wall P.D.
        • et al.
        Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): A multicentre randomised controlled trial.
        Lancet. 2018; 391: 2225-2235
        • Maldonado D.R.
        • Owens J.S.
        • Go C.C.
        • et al.
        Females and males achieved comparable outcomes and clinical benefits following primary hip arthroscopy with labral repair, but age affected outcomes and conversion to total hip arthroplasty. A short and mid-term follow-up analysis with dual stratification.
        Arthroscopy. 2022; 38: 2427-2440
        • Menge T.J.
        • Briggs K.K.
        • Dornan G.J.
        • McNamara S.C.
        • Philippon M.J.
        Survivorship and outcomes 10 years following hip arthroscopy for femoroacetabular impingement: Labral debridement compared with labral repair.
        J Bone Joint Surg Am. 2017; 99: 997-1004
        • Nawabi D.H.
        • Degen R.M.
        • Fields K.G.
        • et al.
        Outcomes after arthroscopic treatment of femoroacetabular impingement for patients with borderline hip dysplasia.
        Am J Sports Med. 2016; 44: 1017-1023
        • Nho S.J.
        • Beck E.C.
        • Nwachukwu B.U.
        • et al.
        Survivorship and outcome of hip arthroscopy for femoroacetabular impingement syndrome performed with modern surgical techniques.
        Am J Sports Med. 2019; 47: 1662-1669
        • Nwachukwu B.U.
        • Chang B.
        • Fields K.
        • et al.
        Outcomes for arthroscopic treatment of anterior inferior iliac spine (subspine) hip impingement.
        Orthop J Sports Med. 2017; 52325967117723109
        • Palmer A.J.R.
        • Gupta V.A.
        • Fernquest S.
        • et al.
        Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: Multicentre randomised controlled trial.
        BMJ. 2019; 364: l185
        • Byrd J.W.T.
        • Jones K.S.
        Arthroscopic acetabular labral repair in patients over the age of 60 years: A matched case-control study.
        Arthroscopy. 2019; 35: 1406-1410
        • Byrd J.W.
        • Jones K.S.
        Hip arthroscopy in athletes: 10-Year follow-up.
        Am J Sports Med. 2009; 37: 2140-2143
        • Philippon M.J.
        • Briggs K.K.
        • Carlisle J.C.
        • Patterson D.C.
        Joint space predicts THA after hip arthroscopy in patients 50 years and older.
        Clin Orthop Relat Res. 2013; 471: 2492-2496
        • Skendzel J.G.
        • Philippon M.J.
        • Briggs K.K.
        • Goljan P.
        The effect of joint space on midterm outcomes after arthroscopic hip surgery for femoroacetabular impingement.
        Am J Sports Med. 2014; 42: 1127-1133
        • Sogbein O.A.
        • Shah A.
        • Kay J.
        • et al.
        Predictors of outcomes after hip arthroscopic surgery for femoroacetabular impingement: A systematic review.
        Orthop J Sports Med. 2019; 72325967119848982
        • Campbell K.J.
        • Boykin R.E.
        • Wijdicks C.A.
        • Giphart J.E.
        • LaPrade R.F.
        • Philippon M.J.
        Treatment of a hip capsular injury in a professional soccer player with platelet-rich plasma and bone marrow aspirate concentrate therapy.
        Knee Surg Sports Traumatol Arthrosc. 2013; 21: 1684-1688
        • Mannava S.
        • Chahla J.
        • Geeslin A.G.
        • et al.
        Platelet-rich plasma augmentation for hip arthroscopy.
        Arthrosc Tech. 2017; 6: e763-e768
        • Nazal M.R.
        • McCarthy M.R.
        • Mazzocca A.D.
        • Martin S.D.
        Connective tissue progenitor analysis of bone marrow aspirate concentrate harvested from the body of the ilium during arthroscopic acetabular labral repair.
        Arthroscopy. 2020; 36: 1311-1320
        • Petrigliano F.A.
        Editorial Commentary: Bone marrow aspirate concentrate harvested from the ilium during acetabular labral repair: Is the biologic juice worth the squeeze?.
        Arthroscopy. 2020; 36: 1321-1322
        • Stelzer J.W.
        • Martin S.D.
        Use of bone marrow aspirate concentrate with acetabular labral repair for the management of chondrolabral junction breakdown.
        Arthrosc Tech. 2018; 7: e981-e987
        • Tönnis D.
        Congenital dysplasia and dislocation of the hip in children and adults.
        Springer, Berlin1987
        • Byrd J.W.
        • Jones K.L.
        • Bardowski E.A.
        Influence of Tonnis grade on outcomes of arthroscopy for FAI in athletes: A comparative analysis.
        J Hip Preserv Surg. 2018; 5: 162-165
        • Scarpone M.
        • Kuebler D.
        • Chambers A.
        • et al.
        Isolation of clinically relevant concentrations of bone marrow mesenchymal stem cells without centrifugation.
        J Transl Med. 2019; 17: 10
        • Nwachukwu B.U.
        • Beck E.C.
        • Kunze K.N.
        • Chahla J.
        • Rasio J.
        • Nho S.J.
        Defining the clinically meaningful outcomes for arthroscopic treatment of femoroacetabular impingement syndrome at minimum 5-year follow-up.
        Am J Sports Med. 2020; 48: 901-907
        • Chahal J.
        • Van Thiel G.S.
        • Mather III, R.C.
        • et al.
        The patient acceptable symptomatic state for the modified Harris Hip Score and Hip Outcome Score among patients undergoing surgical treatment for femoroacetabular impingement.
        Am J Sports Med. 2015; 43: 1844-1849
        • Maxwell S.
        • Pergaminelis N.
        • Renouf J.
        • Tirosh O.
        • Tran P.
        Identification of a patient acceptable symptomatic state score for the International Hip Outcome Tool in people undergoing hip arthroscopy.
        Arthroscopy. 2018; 34: 3024-3029
        • Nwachukwu B.U.
        • Chang B.
        • Fields K.
        • et al.
        Defining the "substantial clinical benefit" after arthroscopic treatment of femoroacetabular impingement.
        Am J Sports Med. 2017; 45: 1297-1303
        • Domb B.G.
        • Chaharbakhshi E.O.
        • Rybalko D.
        • Close M.R.
        • Litrenta J.
        • Perets I.
        Outcomes of hip arthroscopic surgery in patients with Tönnis grade 1 osteoarthritis at a minimum 5-year follow-up: A matched-pair comparison with a Tönnis grade 0 control group.
        Am J Sports Med. 2017; 45: 2294-2302
        • Chandrasekaran S.
        • Darwish N.
        • Gui C.
        • Lodhia P.
        • Suarez-Ahedo C.
        • Domb B.G.
        Outcomes of hip arthroscopy in patients with Tönnis grade-2 osteoarthritis at a mean 2-year follow-up: Evaluation using a matched-pair analysis with Tönnis grade-0 and grade-1 cohorts.
        J Bone Joint Surg Am. 2016; 98: 973-982
        • Domb B.G.
        • Gui C.
        • Lodhia P.
        How much arthritis is too much for hip arthroscopy: A systematic review.
        Arthroscopy. 2015; 31: 520-529
        • Haviv B.
        • O’Donnell J.
        The incidence of total hip arthroplasty after hip arthroscopy in osteoarthritic patients.
        Sports Med Arthrosc Rehabil Ther Technol. 2010; 2: 18
        • Arshi A.
        • Petrigliano F.A.
        • Williams R.J.
        • Jones K.J.
        Stem cell treatment for knee articular cartilage defects and osteoarthritis.
        Curr Rev Musculoskelet Med. 2020; 13: 20-27
        • McCarrel T.
        • Fortier L.
        Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression.
        J Orthop Res. 2009; 27: 1033-1042
        • Cotter E.J.
        • Wang K.C.
        • Yanke A.B.
        • Chubinskaya S.
        Bone marrow aspirate concentrate for cartilage defects of the knee: From bench to bedside evidence.
        Cartilage. 2018; 9: 161-170
        • Hernigou P.
        • Lachaniette C.H.F.
        • Delambre J.
        • et al.
        Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: A case-controlled study.
        Int Orthop. 2014; 38: 1811-1818
        • Hernigou P.
        • Poignard A.
        • Manicom O.
        • Mathieu G.
        • Rouard H.
        The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone.
        J Bone Joint Surg Br. 2005; 87: 896-902
        • Gobbi A.
        • Karnatzikos G.
        • Sankineani S.R.
        One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee.
        Am J Sports Med. 2014; 42: 648-657
        • Hede K.
        • Christensen B.B.
        • Jensen J.
        • Foldager C.B.
        • Lind M.
        Combined bone marrow aspirate and platelet-rich plasma for cartilage repair: Two-year clinical results.
        Cartilage. 2021; 13 (suppl): 937S-947S
        • Chahla J.
        • Dean C.S.
        • Moatshe G.
        • Pascual-Garrido C.
        • Serra Cruz R.
        • LaPrade R.F.
        Concentrated bone marrow aspirate for the treatment of chondral injuries and osteoarthritis of the knee: A systematic review of outcomes.
        Orthop J Sports Med. 2016; 42325967115625481
        • Saw K.Y.
        • Hussin P.
        • Loke S.C.
        Articular cartilage regeneration with autologous marrow aspirate and hyaluronic acid: An experimental study in a goat model.
        Arthroscopy. 2009; 25: 1391-1400
        • Centeno C.
        • Pitts J.
        • Al-Sayegh H.
        • Freeman M.
        Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft.
        Biomed Res Int. 2014; 2014370621
        • Hauser R.A.
        • Orlofsky A.
        Regenerative injection therapy with whole bone marrow aspirate for degenerative joint disease: A case series.
        Clin Med Insights Arthritis Musculoskelet Disord. 2013; 6: 65-72
        • Kim J.D.
        • Lee G.W.
        • Jung G.H.
        Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee.
        Eur J Orthop Surg Traumatol. 2014; 24: 1505-1511
        • Mishima H.
        • Sugaya H.
        • Yoshioka T.
        • et al.
        The safety and efficacy of combined autologous concentrated bone marrow grafting and low-intensity pulsed ultrasound in the treatment of osteonecrosis of the femoral head.
        Eur J Orthop Surg Traumatol. 2016; 26: 293-298
        • Hauzeur J.P.
        • De Maertelaer V.
        • Baudoux E.
        • Malaise M.
        • Beguin Y.
        • Gangji V.
        Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: A randomized controlled double-blind trial.
        Int Orthop. 2018; 42: 1429-1435
        • Cruz-Pardos A.
        • Garcia-Rey E.
        • Ortega-Chamarro J.A.
        • Duran-Manrique D.
        • Gomez-Barrena E.
        Mid-term comparative outcomes of autologous bone-marrow concentration to treat osteonecrosis of the femoral head in standard practice.
        Hip Int. 2016; 26: 432-437
        • Piuzzi N.S.
        • Chahla J.
        • Schrock J.B.
        • et al.
        Evidence for the use of cell-based therapy for the treatment of osteonecrosis of the femoral head: A systematic review of the literature.
        J Arthroplasty. 2017; 32: 1698-1708
        • Bajwa A.S.
        • Villar R.N.
        Mesenchymal stem cells (MSC) use in hip arthroscopy: Medium term results in case-control study of patients with ICRS grade 2-4 defects?.
        J Hip Preserv Surg. 2016; 3 (hnw030.043)